Newsfeeds - Spark Newswire

1 minute read

Sanofi-Regeneron’s Flagship Drug Shows Consistent Efficacy, Safety Profile At Two Years For Asthma In Kids

September 6, 7:10 AM

Regeneron Pharmaceuticals Inc (NASDAQ:REGN) and Sanofi SA (NASDAQ:SNY) announced results from a Phase 3 open-label extension trial of Dupixent (dupilumab) as maintenance therapy…

REGN

7 minute read

Sanofi’s Rare Disease Drug Xenpozyme Scores FDA Approval

By Vandana Singh

September 1, 6:51 AM

Soon after the European Commission’s (EC) approval, Sanofi SA (NASDAQ:SNY) scooped up the FDA’s OK for the first approved therapy to treat symptoms…

SNY

6 minute read

Bluebird bio Seeks Back-to-Back Nods, ‘Go’ or ‘No-Go’ For Revance’s Botox Rival, Amylyx’ Twin Hurdles And More: September’s Key PDUFA Catalysts Biotech Investors Must Know

By Shanthi Rexaline

August 31, 2:52 PM

After August’s mixed tally for Food and Drug Administration approvals, investors turn to a new month, which has a fairly loaded calendar.

ACAD

1 minute read

Xenpozyme Approved By FDA As First Disease-Specific Treatment For ASMD

By Benzinga Newsdesk

August 31, 2:32 PM

Paris, August 31, 2022. The U.S. Food and Drug Administration (FDA) has approved XenpozymeTM (olipudase alfa-rpcp) for the treatment of non-central nervous system (non-CNS) manifestations of acid sphingomyelinaseParis, August 31, 2022. The U.S.

SNY

1 minute read

With Approval For Dengue Vaccine, Takeda May Find It Challenging To Compete Bigger Rivals: Report

By Vandana Singh

August 30, 12:28 PM

Last week, Takeda Pharmaceutical Co Ltd’s (NYSE:TAK) dengue vaccine, Qdenga, was approved in Indonesia for individuals six to 45 years of age.…

GSK

1 minute read

Sanofi’s Hemophilia Candidate Goes Under Priority FDA Review

By Vandana Singh

August 30, 6:46 AM

The FDA has accepted for priority review Sanofi SA’s (NASDAQ:SNY) marketing application for efanesoctocog alfa (BIVV001) for hemophilia A, a rare…

BIOVF

1 minute read

Sanofi Higher Dose Flu Vaccines Preferentially Recommended For Adults 65+ In CDC Morbidity And Mortality Weekly Report

By Benzinga Newsdesk

August 26, 8:04 AM

This recommendation may help reduce the risk of the flu and flu-related complications in this high-risk population Fluzone® High-Dose Quadrivalent (Influenza Vaccine) and

SNY